Archive · 15 Sep 2026
Max Healthcare Stock Breaks Out, Target Set At ₹1,200
Max Healthcare Institute’s share price had been falling since early July.
It found support around ₹980 in mid-August, meaning buyers helped prevent it from falling further.
The stock stayed above that level for about a month and built a base.
Last week, it rose above ₹1,030, a level that had limited its gains.
The article says this may mean the stock’s upward trend is starting again.
Traders are advised to buy around ₹1,037.
They can buy more if the price falls to ₹1,010.
The suggested first stop-loss is ₹960, and profits should be booked at ₹1,200.
The article expects the stock to reach ₹1,200 within a year.
Max Healthcare Institute’s stock declined from early July before finding support near ₹980 in mid-August.
The stock traded above ₹980 for about a month and formed a base.
It rallied last week and broke above resistance at ₹1,030.
The article says the breakout signals a resumption of the uptrend after a temporary correction.
Traders are advised to buy near ₹1,037, with staged stop-losses and profit booking at ₹1,200.
- Who
- Traders and investors considering Max Healthcare Institute shares.
- What
- A trading recommendation to buy Max Healthcare Institute after a breakout above ₹1,030.
- When
- The update is for September 15, 2026; the breakout occurred the previous week.
- Where
- The Indian stock market.
- Why
- The stock formed a base above ₹980 and broke through ₹1,030 resistance, which the article says indicates a resumed uptrend.
- Stock
- Max Healthcare Institute
- Reference price
- ₹1,037.20
- Support level
- ₹980
- Breakout level
- ₹1,030
- Suggested accumulation price
- ₹1,010
- Initial stop-loss
- ₹960
- Profit target
- ₹1,200 within a year